Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.
Publication
, Journal Article
T Low, J; B Peters, K
Published in: CNS Oncol
March 1, 2020
The standard regimen for the treatment of newly diagnosed primary CNS lymphoma (PCNSL) remains regimens that contain high-dose methotrexate (MTX). While these regimens can provide control for some patients, there is a dearth of options for the treatment of patients with PCNSL who cannot tolerate MTX-containing regimens, or whose cancers are refractory to MTX. In this article, we review a promising new option; ibrutinib, a Bruton tyrosine kinase inhibitor, for patients with relapsed and refractory PCNSL.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
CNS Oncol
DOI
EISSN
2045-0915
Publication Date
March 1, 2020
Volume
9
Issue
1
Start / End Page
CNS51
Location
England
Related Subject Headings
- Prognosis
- Piperidines
- Lymphoma, Large B-Cell, Diffuse
- Humans
- Central Nervous System Neoplasms
- Adenine
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
T Low, J., & B Peters, K. (2020). Ibrutinib in primary central nervous system diffuse large B-cell lymphoma. CNS Oncol, 9(1), CNS51. https://doi.org/10.2217/cns-2019-0022
T Low, Justin, and Katherine B Peters. “Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.” CNS Oncol 9, no. 1 (March 1, 2020): CNS51. https://doi.org/10.2217/cns-2019-0022.
T Low J, B Peters K. Ibrutinib in primary central nervous system diffuse large B-cell lymphoma. CNS Oncol. 2020 Mar 1;9(1):CNS51.
T Low, Justin, and Katherine B Peters. “Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.” CNS Oncol, vol. 9, no. 1, Mar. 2020, p. CNS51. Pubmed, doi:10.2217/cns-2019-0022.
T Low J, B Peters K. Ibrutinib in primary central nervous system diffuse large B-cell lymphoma. CNS Oncol. 2020 Mar 1;9(1):CNS51.
Published In
CNS Oncol
DOI
EISSN
2045-0915
Publication Date
March 1, 2020
Volume
9
Issue
1
Start / End Page
CNS51
Location
England
Related Subject Headings
- Prognosis
- Piperidines
- Lymphoma, Large B-Cell, Diffuse
- Humans
- Central Nervous System Neoplasms
- Adenine
- 3211 Oncology and carcinogenesis